Healthcare provider profile · identity verified

Sarah Stapleton, MD

Internal Medicine · CHARLESTON, SC · NPI 1760441554

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	490	120
Levothyroxine Sodium	Levothyroxine Sodium	377	77
Losartan Potassium	Losartan Potassium	306	67
Atorvastatin Calcium	Atorvastatin Calcium	301	74
Sertraline Hcl	Sertraline Hcl	286	56
Ezetimibe	Ezetimibe	267	61
Eliquis	Apixaban	237	40
Amlodipine Besylate	Amlodipine Besylate	231	58
Gabapentin	Gabapentin	227	47
Famotidine	Famotidine	189	44
Escitalopram Oxalate	Escitalopram Oxalate	178	30
Trazodone Hcl	Trazodone Hcl	176	36
Metoprolol Succinate	Metoprolol Succinate	133	34
Duloxetine Hcl	Duloxetine Hcl	128	24
Azithromycin	Azithromycin	122	79
Zolpidem Tartrate	Zolpidem Tartrate	121	34
Ozempic	Semaglutide	119	17
Metformin Hcl Er	Metformin Hcl	115	32
Omeprazole	Omeprazole	113	27
Lorazepam	Lorazepam	111	29
Meloxicam	Meloxicam	105	28
Celecoxib	Celecoxib	104	19
Furosemide	Furosemide	99	34
Bupropion Xl	Bupropion Hcl	95	24
Myrbetriq	Mirabegron	93	21
Tamsulosin Hcl	Tamsulosin Hcl	92	30
Esomeprazole Magnesium	Esomeprazole Magnesium	89	25
Lisinopril	Lisinopril	89	23
Olmesartan Medoxomil	Olmesartan Medoxomil	88	21
Solifenacin Succinate	Solifenacin Succinate	86	22
Synthroid	Levothyroxine Sodium	86	22
Alprazolam	Alprazolam	82	19
Simvastatin	Simvastatin	79	18
Fluoxetine Hcl	Fluoxetine Hcl	77	14
Pantoprazole Sodium	Pantoprazole Sodium	69	19
Tramadol Hcl	Tramadol Hcl	69	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	68	16
Clonazepam	Clonazepam	64	14
Estradiol	Estradiol	59	16
Potassium Chloride	Potassium Chloride	59	15
Venlafaxine Hcl Er	Venlafaxine Hcl	57	suppressed
Tizanidine Hcl	Tizanidine Hcl	54	24
Alendronate Sodium	Alendronate Sodium	53	15
Donepezil Hcl	Donepezil Hcl	53	13
Hydrochlorothiazide	Hydrochlorothiazide	52	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	36
Telmisartan	Telmisartan	49	13
Mirtazapine	Mirtazapine	48	suppressed
Spironolactone	Spironolactone	48	11
Allopurinol	Allopurinol	47	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	31
Diazepam	Diazepam	45	11
Montelukast Sodium	Montelukast Sodium	45	12
Valacyclovir	Valacyclovir Hcl	44	22
Valsartan	Valsartan	42	suppressed
Mounjaro	Tirzepatide	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	36	35
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	18
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Dutasteride	Dutasteride	27	suppressed
Prednisone	Prednisone	27	15
Temazepam	Temazepam	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Metformin Hcl	Metformin Hcl	25	suppressed
Finasteride	Finasteride	24	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Fluconazole	Fluconazole	20	14
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Pentoxifylline	Pentoxifylline	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Amoxicillin	Amoxicillin	19	14
Jardiance	Empagliflozin	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	14
Depakote Er	Divalproex Sodium	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Atenolol	Atenolol	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Trintellix	Vortioxetine Hydrobromide	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Alprazolam Xr	Alprazolam	13	suppressed
Colchicine	Colchicine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Ketoconazole	Ketoconazole	13	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Testosterone	Testosterone	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Carvedilol Er	Carvedilol Phosphate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Entresto	Sacubitril/Valsartan	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Veozah	Fezolinetant	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Erythromycin	Erythromycin Base	11	11
Labetalol Hcl	Labetalol Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error